Opus Genetics (IRD) Asset Utilization Ratio (2020 - 2026)

Opus Genetics (IRD) has 7 years of Asset Utilization Ratio data on file, last reported at 0.2 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.2, down 36.22% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.2 (down 36.22% YoY), and the FY2025 annual result was 0.33, up 34.64% from the prior year.
• Asset Utilization Ratio declined to 0.2 in Q1 2026 per IRD's latest filing, from 0.33 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 1.25 in Q4 2022 and troughed at 0.03 in Q1 2022.
• A 5-year average of 0.47 and a median of 0.35 in 2023 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio soared 5145.76% in 2022, then plunged 83.21% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 1.25 in 2022, then slumped by 71.9% to 0.35 in 2023, then dropped by 19.22% to 0.28 in 2024, then climbed by 15.52% to 0.33 in 2025, then slumped by 37.71% to 0.2 in 2026.
• Business Quant data shows IRD's Asset Utilization Ratio at 0.2 in Q1 2026, 0.33 in Q4 2025, and 0.39 in Q3 2025.